Susan Hasty, Publisher
Table of Contents . . . October 12th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Health Risk Factor Week | Other Publications
Central University of the Caribbean - Study reviews evidence for aspirin in treatment and prevention of CV disease
Complementary & Alternative Medicine - Organic market growth has caused scientists to seek proof of organic claims
Eli Lilly & Company - Emerging drug targets for treatment of obesity reviewed
Health Canada - Aurintricarboxylic acid inhibits SARS coronavirus replication
NascaCell - Drug discovery company announces a collaboration agreement with Aventis
PediaMed - Pediatric company donates cough and cold medication to AmeriCares
AHF - Reported Los Angeles County AIDS cases up 89% over past 2 years
Aaron Diamond AIDS Research Center - TRIM5alpha important natural barrier to cross-species retrovirus transmission
Abiomed, Inc. - Device company appoints European general manager
AcroSoft Corporation - Trumbull Services Inc. installs insurance content management system
Alnylam Pharmaceuticals, Inc. - Pharmaceutical company appoints Robert Millman as chief patent counsel
Altana AG - Marketing approval granted for Alvesco in Brazil and Mexico
Amarillo Biosciences, Inc. - Oral interferon rights licensed to Nobel to treat Behcet disease
American Pharmaceutical Partners - Pharmaceutical firm extends partnerships with business management company
American Society for Therapeutic Radiology - Cancer research presented at meeting in Atlanta
Amgen, Inc. - Biotech firm names Arvind Sood VP, investor relations
Asthma - AAAAI and AAP announce "Living with Asthma" poster contest
AstraZeneca - Data confirm 30% 1-year survival for gefitinib in non-small cell lung cancer
AstraZeneca - FDA committee wants more data to support approval of Exanta
AstraZeneca - Mutual Recognition Procedure finalized for new Nexium indications
Austrian Academy of Sciences - Coding of vowel-like signals characterized in cochlear implant users
Auxilium Pharmaceuticals - Positive results released for a phase IV study of Testim 1%
Aventis Pasteur, Inc. - U.S. may buy experimental bird flu vaccine
Awards - Hospitalists receive 2004 John M. Eisenberg Patient Safety and Quality Awards
Beijing Institute of Radiation Medicine - Sphingosine kinase modulates hepatocyte growth factor-induced cell migration
BioForce Nanosciences - Grant award to fund NanoReader device to target detection of whole viruses
BioPharma Inc - Biopharma company forms scientific advisory board
BioRexis Pharmaceutical Corporation - Frederick Jones appointed head of business development at pharma firm
Biomerica, Inc. - Diagnostics company reports 1.2% increase in sales
Biophan Technologies, Inc. - John Lanzafame named president of Nanolution division
Biota Holdings Limited - Australian biotech firm announces share purchase plan
Blue Cross of California - Views on insurance differ among insured and uninsured women business owners
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.